RET genomic alterations in NSCLC disrupt the physiological activation of proliferating and apoptotic pathways as well as differentiation and chemotaxis, ultimately leading to uncontrolled cell growth [10]. This evidence concerns the gene RET and non-small cell lung carcinoma.